Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10031 |
| Vaccine Name | Covaxin |
| Disease Name | COVID-19 |
| Disease Classification | Respiratory |
| Virus Name | SARS-CoV-2 virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Inactivated |
| Vaccine Status | Approved |
| Manufacturer | Bharat Biotech International Limited |
| Year of Manufacturing | 2021 |
| Manufacturing Country | India |
| Age | 18 years and above |
| Dosage | NA |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | NA |
| Description | NA |
| Approving Organisation | DCGI, WHO |
| Collaborating Organisation | Indian Council of Medical Research, Iqvia Pty Ltd |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NCT04641481 |
| Reference Link | https://clinicaltrials.gov/ct2/show/NCT04641481 |
| Additional Links | https://www.clinicaltrialsarena.com/projects/covaxin-bbv152-for-the-treatment-of-covid-19/ |